tiprankstipranks
Trending News
More News >

Mark Alan Smith Insider Profile

4 Followers
Mark Alan Smith, CMO at VistaGen Therapeutics, holds 19.91K shares in VistaGen Therapeutics (Ticker: VTGN).
tipranks
Mark Alan Smith

Mark Alan Smith
VistaGen Therapeutics (VTGN)
CMO

Not Ranked
Mark Alan Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$80K
100.00%
A breakdown of Mark Alan Smith's holdings

Insider Roles

VistaGen Therapeutics
(VTGN)
CMO
Roles that Mark Alan Smith holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Mark Alan Smith

Mark Alan Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
VistaGen Therapeutics
Jul 15, 2022
CMO
Uninformative Buy
3.70K
$80.26K
Mark Alan Smith has not reported any informative transactions for VTGN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 01, 2020
Uninformative Buy
$2.20K
-
$0.44
Jan 04, 2021
Uninformative Buy
$2.25K
-
$0.45
Jul 02, 2021
Uninformative Buy
$4.38K
-
$1.94
Jan 03, 2022
Uninformative Buy
$4.38K
-
$1.65
Jul 15, 2022
Uninformative Buy
$3.70K
-
$0.74
List of latest transactions for each holding click on a transaction to see Mark Alan Smith's performance on stock

Mark Alan Smith insider profile FAQ

What is the percentage of profitable transactions made by Mark Alan Smith?
The percentage of profitable transactions made by Mark Alan Smith is ―.
    What is the average return per transaction made by Mark Alan Smith?
    The average return per transaction made by Mark Alan Smith is ―.
      What stocks does Mark Alan Smith hold?
      Mark Alan Smith holds: VTGN stocks.
        What was Mark Alan Smith’s latest transaction?
        Mark Alan Smith latest transaction was an Uninformative Buy of $3.70K.
          What was Mark Alan Smith's most profitable transaction?
          Mark Alan Smith’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Mark Alan Smith's role in VistaGen Therapeutics?
            Mark Alan Smith's role in VistaGen Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.